Ahmed T - Search Results

1

Homoharringtonine is safe and effective for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Among authors: ahmed t. Leukemia. 1992 Nov;6(11):1185-8. Leukemia. 1992. PMID: 1434802 Clinical Trial.

2

Long-term follow-up of high-dose mitoxantrone-based induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Twelve year results from a single institution.

Seiter K, Liu D, Feldman E, Shi Q, Qureshi A, Arshad M, Walia T, Naseer N, Baskind P, Ahmed T. Seiter K, et al. Among authors: ahmed t. Leuk Lymphoma. 2006 Mar;47(3):425-32. doi: 10.1080/10428190500331600. Leuk Lymphoma. 2006. PMID: 16396765 Clinical Trial.

3

Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Among authors: ahmed t. Leukemia. 1992 Nov;6(11):1189-91. Leukemia. 1992. PMID: 1434803 Clinical Trial.

4

Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapy.

Arlin ZA, Ahmed T, Mittelman A, Cook P, Puccio CA, Helson L, Chun HG. Arlin ZA, et al. Among authors: ahmed t. Int J Clin Lab Res. 1992;21(4):273-7. doi: 10.1007/BF02591660. Int J Clin Lab Res. 1992. PMID: 1591379 Review.

5

Age, phenotype, and curability in acute myelogenous leukemia.

Arlin Z, Feldman E, Finger L, Mittelman A, Ahmed T. Arlin Z, et al. Among authors: ahmed t. Cancer Invest. 1991;9(6):655-7. doi: 10.3109/07357909109039877. Cancer Invest. 1991. PMID: 1747792 No abstract available.

6

"Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment.

Arlin ZA, Feldman EJ, Finger L, Ahmed T, Mittelman A, Puccio C, Cook P, Chun HG. Arlin ZA, et al. Among authors: ahmed t. Semin Hematol. 1991 Jul;28(3 Suppl 4):44-7. Semin Hematol. 1991. PMID: 1780752 Review. No abstract available.

7

Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia.

Arlin ZA, Feldman EJ, Mittelman A, Ahmed T, Puccio C, Chun HG, Cook P, Baskind P, Marboe C, Mehta R. Arlin ZA, et al. Among authors: ahmed t. Cancer. 1991 Sep 15;68(6):1198-200. doi: 10.1002/1097-0142(19910915)68:6<1198::aid-cncr2820680603>3.0.co;2-e. Cancer. 1991. PMID: 1873770

8

Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia.

Arlin ZA, Feldman EJ, Finger LR, Ahmed T, Mittelman A, Cook P, Puccio C, Baskind P, Arnold P, Razis ED, et al. Arlin ZA, et al. Among authors: ahmed t. Leukemia. 1991 Aug;5(8):712-4. Leukemia. 1991. PMID: 1886423

9

Further thoughts on 'cell kill' in acute leukemia.

Arlin ZA, Hiddemann W, Feldman E, Mittelman A, Ahmed T. Arlin ZA, et al. Among authors: ahmed t. Acta Haematol. 1991;85(1):1-5. doi: 10.1159/000204842. Acta Haematol. 1991. PMID: 2011923 Review.

10

Intensive chemotherapy with interferon for induction of true remission in chronic phase of chronic myelogenous leukemia.

Arlin Z, Feldman E, Ahmed T, Mittelman A, Puccio C, Biguzzi S. Arlin Z, et al. Among authors: ahmed t. Cancer Invest. 1990;8(2):303. doi: 10.3109/07357909009017597. Cancer Invest. 1990. PMID: 2400954 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,876 results

Search Page

Filters